Happy Nice Mall

Senior management officials, speaking on condition of anonymity, insisted on Tuesday evening that the White House would not announce any new funding commitments, but that there would be “strong funds going forward.” Mr. Biden has appealed to Congress for appropriate money to create a health research initiative modeled after the Pentagon’s Defense Advanced Research Projects Agency, known as DARPA.

The White House billed the incident as a new push by the president to “reignite” the moonlight program and “end cancer as we know it.” Mr. Biden specifically set a goal of reducing the age-adjusted death rate by more than half over the next 25 years. But there were few details on how to achieve this goal.

“These are bold targets and I have no doubt they will be mechanisms to achieve them,” said Ellen V. Sigal, founder of Friends of Cancer Research, which works to support cancer research and provide new treatments to patients. in the background.

There’s Mr. Biden it’s already called Danielle CarnivalDuring the Obama administration, she worked on the moonshot program to help oversee the new version of the effort. Now, the president has said, the “cancer cabinet” will coordinate the work of multiple government agencies.

The White House said more than 9.5 million cancer screenings were missed in the United States as a result of the pandemic. Mr Biden is urging the cancer institute, an arm of the National Institutes of Health, to coordinate with cancer treatment centers to offer screenings nationwide and develop a program to accelerate the development of tests that can detect multiple types. cancer at once.

New blood tests that are said to detect all cancers are still unproven, and there are currently no plans to do very large studies that could determine whether it actually prevents death and harms people with unnecessary treatments. But companies interested in them were excited by Mr. Biden’s announcement.

“Making early cancer detection more affordable and accessible, especially for traditionally underserved groups, is the next step in reducing cancer death rates,” said Francis deSouza, CEO of Illumina, a medical device company. Said.